New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

CIMZIA (certolizumab pegol) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email to discuss.

CIMZIA is a tumor necrosis factor (TNF) blocker indicated for:
• Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
• Treatment of adults with moderately to severely active rheumatoid arthritis
• Treatment of adult patients with active psoriatic arthritis.

Brand Name: CIMZIA (certolizumab pegol) injection, for subcutaneous use Initial U.S. Approval: 2008.
API: certolizumab pegol
Dosage Forms & Strengths:
For injection:
• For injection: 200 mg lyophilized powder for reconstitution in a single use vial, with 1 mL of sterile Water for Injection.
• Injection: 200 mg/mL solution in a single-use prefilled syringe.
Manufactured By: UCB, Inc.
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “CIMZIA (certolizumab pegol) injection” to all locations in India after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Query Form


Medical uses of CIMZIA (certolizumab pegol) injection

  • Crohn’s Disease
    On April 22, 2008, the U.S. Food and Drug Administration (FDA) approved Cimzia for the treatment of Crohn’s disease.
  • Rheumatoid arthritis
    On June 26, 2009, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that the European Commission grant a marketing authorisation for Cimzia for the treatment of rheumatoid arthritis only/
  • Psoriatic arthritis
    On September 27, 2013, the U.S. FDA approved Cimzia for the treatment of adult patients with active psoriatic arthritis.

South Delhi Pharma Can Supply certolizumab pegol In India On Request –

certolizumab pegol, sold under the brand name CIMZIA®, is manufactured by UCB, Inc.. It has been approved by the FDA. For pricing information on CIMZIA® in India, please contact via phone or WhatsApp at +91-9891296838 or email at CIMZIA® is supplied in form: For injection. It can be made available in various cities across India, including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim.


  • FDA approves treatment for patients with a type of inflammatory arthritis For More Details 
  • FDA Approves Abrilada, Biosimilar to Humira, for Adults with Ankylosing Spondylitis and Other Disorders For More Details 

Related Products